COMMUNIQUÉS West-GlobeNewswire

-
NightHawk Receives Proceeds of $3.25 Million in Connection with Sale of Non-Core Intellectual Property and Issuance of a Low Interest Bearing Note
30/01/2024 -
Accompany Health Launches to Care for Low-Income Patients with Complex Needs
30/01/2024 -
MiNK’s AgenT-797 Offers New Hope in Overcoming ICI Resistance in PD-1 Refractory Gastric Cancer - Published in Oncogene
30/01/2024 -
Immutep Quarterly Activities Report Q2 FY24
30/01/2024 -
Tome Biosciences Appoints Industry Veteran Daniel Curran, MD, to its Board of Directors
30/01/2024 -
ProSomnus Severe Indication 510(k) Submission Accepted for Review by the FDA
30/01/2024 -
iCAD Expands Board of Directors with Appointment of Michael J. Doyle, FACHE as New Board Member
30/01/2024 -
Bionano’s Symposium 2024 Featured Presentations from its Global User Community Highlighting OGM as a Powerful Alternative to Classical Cytogenetics and Strong Complement to NGS
30/01/2024 -
ProPhase Labs Ushers in New Genomics Era with Jason Karkus at the Helm of Nebula Genomics
30/01/2024 -
Spectral Medical Provides January Tigris Trial Update
30/01/2024 -
Avicanna and Ease Labs Pharma Granted Commercialization Approval for Pharmaceutical Preparation in Brazil
30/01/2024 -
Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal Matters
30/01/2024 -
VPR Brands Triumphs Again in PTAB Ruling, Upholding Key Electronic Cigarette Patent
30/01/2024 -
Kraig Biocraft Laboratories Signs Pivotal MOU in Vietnam's Silk Production Capital
30/01/2024 -
Regeneron Announces Formation of Regeneron Cell Medicines with the Acquisition of 2seventy bio Platforms and Preclinical and Clinical Programs
30/01/2024 -
ITM and Alpha-9 Oncology Announce Global Supply Agreement to Support Alpha-9’s Clinical Radiopharmaceutical Development Program
30/01/2024 -
As Omicron subvariants continue their worldwide transmission, CoVaRR-Net awarded another year of funding
30/01/2024 -
Alors que la transmission de sous-variants d'Omicron se poursuit dans le monde, une nouvelle année de financement est octroyée au réseau CoVaRR-Net
30/01/2024 -
Kura Oncology Reports Positive Preliminary Ziftomenib Combination Data in Acute Myeloid Leukemia
30/01/2024
Pages